[1] Daughton C G, Ternes T A. Pharmaceuticals and personal care roducts in the environment:Agents of subtle change[J]. Environ.ealth Perspect, 1999, 107(6):907-942.
[2] Boyd G R, Palmeri J M, Zhang S, et al. Pharmaceuticals and personal care products(PPCPs) and endocrine disrupting chemicals(EDCs) n stormwater canals and Bayou St. John in New Orleans, Louisiana, USA[J]. Science of the Total Environment, 2004, 333(1/2/3):37-148.
[3] McClellan K, Halden R U. Pharmaceuticals and personal care pro-ucts in archived U. S. biosolids from the 2001 EPA national sewage sludge survey[J]. Water Research, 2010, 44(2):658-668.
[4] Gros M, Petrovic M, Ginebreda A, et al. Removal of pharmaceuticals during wastewater treatment and environmental risk assessment using hazard indexes [J]. Environment International, 2010, 36(1):5-26.
[5] Fent K, Weston A A, Caminada D. Ecotoxicology of human pharmaceuticals[J]. Aquatic Toxicology, 2006, 76(2):122-159.
[6] Jelic A, Gros M, Ginebreda A, et al. Occurrence, partition and removal of pharmaceuticals in sewage water and sludge during waste-ater treatment[J]. Water Research, 2011, 45(3):1165-1176.
[7] Sui Q, Wang B, Zhao W, et al. Identification of priority pharmaceuticals in the water environment of China[J]. Chemosphere, 2012, 89(3):280-286.
[8] Al-Rifai J H, Khabbaz H, Schäfer A I. Removal of pharmaceuticals and endocrine disrupting compounds in a water recycling process using reverse osmosis systems[J]. Separation and Purification Technology, 2011, 77(1):60-67.
[9] Lishman L, Smyth S A, Sarafin K, et al. Occurrence and reductions of pharmaceuticals and personal care products and estrogens by municipal wastewater treatment plants in Ontario, Canada[J]. Science of the Total Environment, 2006, 367(2/3):544-558.
[10] Wick A, Fink G, Joss A, et al. Fate of beta blockers and psycho-active drugs in conventional wastewater treatment[J]. Water Re-earch, 2009, 43(4):1060-1074.
[11] Verlicchi P, Al Aukidy M, Zambello E. Occurrence of pharmaceutical compounds in urban wastewater:Removal, mass load and environmental risk after a secondary treatment—A review[J]. Science of the Total Environment, 2012, 429:123-155.
[12] Xue Wenchao, Wu Chunying, Xiao Kang, et al. Elimination and fate of selected micro-organic pollutants in a full-scale anaerobic/anoxic/aerobic process combined with membrane bioreactor for municipal wastewater reclamation[J]. Water Research, 2010, 44(20):5999-6010.
[13] Lin A Y, Yu T H, Lateef S K. Removal of pharmaceuticals in secon-ary wastewater treatment processes in Taiwan[J]. Journal of Hazar-ous Materials, 2009, 167(1/2/3):1163-1169.
[14] Leung H W, Minh T B, Murphy M B, et al. Distribution, fate and risk assessment of antibiotics in sewage treatment plants in Hong Kong, South China [J]. Environment International, 2012, 42:1-9.
[15] Gulkowska A, Leung H W, So M K, et al. Removal of antibiotics from wastewater by sewage treatment facilities in Hong Kong and Shenzhen, China[J]. Water Research, 2008, 42(1/2):395-403.
[16] Clara M, Strenn B, Gans O, et al. Removal of selected pharmaceuticals, fragrances and endocrine disrupting compounds in a membrane bioreactor and conventional wastewater treatment plants[J]. Water Research, 2005, 39(19):4797-4807.
[17] Jia Ai, Wan Yi, Xiao Yang, et al. Occurrence and fate of quinolone and fluoroquinolone antibiotics in a municipal sewage treatment plant[J]. Water Research, 2012, 46(2):387-394.
[18] Tunkel J, Howard P H, Boethling R S, et al. Predicting ready]iodegradability in the Japanese ministry of international trade and industry test[J]. Environ. Toxicol. Chem., 2000, 19(10):2478-2485.
[19] Jones O A H, Voulvoulis N, Lester J N. Human pharmaceuticals in wastewater treatment processes[J]. Crit. Rev. Env. Sci. Tec., 2005,]5:401-427.
[20] Hai F I, Tessmer K, Nguyen L N, et al. Removal of micropollutants by membrane bioreactor under temperature variation[J]. Journal of Membrane Science, 2011, 383(1/2):144-151.
[21] Carballa M, Omil F, Ternes T, et al. Fate of pharmaceutical and]ersonal care products(PPCPs) during anaerobic digestion of sewage]ludge[J]. Water Research, 2007, 41(10):2139-2150.
[22] Urase T, Kagawa C, Kikuta T. Factors affecting removal of pharmaceutical substances and estrogens in membrane separation bioreactors[J]. Desalination, 2005, 178(1/2/3):107-113.
[23] Lesjean B, Gnirss R, Buisson H, et al. Outcomes of a 2-year investigation on enhanced biological nutrients removal and trace orga-ics elimination in membrane bioreactor(MBR)[J]. Water Sci.]echnol., 2005, 52(10/11):453-460.
[24] Majewsky M, Gall T, Yargeau V, et al. Active heterotrophic biomass]nd sludge retention time(SRT) as determining factors for biode-radation kinetics of pharmaceuticals in activated sludge[J]. Biore-source Technology, 2011, 102(16):7415-7421.